|
|
|
|
|
|
|
April 2008 April 30, 2008 NEW YORK (Reuters Health) - In women with early-stage, hormone receptor-positive breast cancer, extended therapy with the steroidal aromatase inhibitor exemestane after 5 years of treatment with tamoxifen significantly improves relapse-free survival, according to an analysis of the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-33 trial. April 30, 2008 NEW YORK (Reuters Health) - For men aged 70 years and older with prostate cancer but without major co-morbidities and who have a life expectancy of at least 10 years, radical retropubic prostatectomy (RRP) is "a real option," a New York investigator told Reuters Health. April 30, 2008 NEW YORK (Reuters Health) - Radioactive microsphere therapy appears to prolong survival in patients with unresectable, chemorefractory metastatic disease of the liver, findings from a prospective, open-label phase II study indicate. April 30, 2008 NEW YORK (Reuters Health) - Certain vitamin D receptor (VDR) gene polymorphisms could affect the risk of breast cancer, as well as the estrogen receptor status of tumors, in postmenopausal women, according to findings from a German study. April 30, 2008 CHICAGO (Reuters) - Five years of cancer care for America's elderly cost Medicare $21.1 billion, a figure that will swell as the baby boomer generation ages, U.S. government researchers said on Tuesday. April 29, 2008 NEW YORK (Reuters Health) - Tetrodotoxin, a sodium channel blocker found in several tetraodon pufferfish may relieve moderate to severe cancer pain, according to findings published in the April issue of the Journal of Pain and Symptom Management. April 29, 2008 NEW YORK (Reuters Health) - By measuring cerebral blood volume (CBV), dynamic susceptibility-weighted contrast-enhanced perfusion MRI can predict the time to progression of high- and low-grade gliomas, according to a report in the May issue of Radiology. Estrogen more suppressed with letrozole than anastrozole April 23, 2008 NEW YORK (Reuters Health) - In postmenopausal women with hormone receptor-positive breast cancer, letrozole suppresses plasma estradiol and estrone sulfate more completely than does anastrozole, according to UK researchers. April 23, 2008 NEW YORK (Reuters Health) - Women who are carriers of BRCA1/2 gene mutations that put them high risk for cancer may opt to undergo mastectomy and ovary removal as a cancer prevention strategy. Now, a small study suggests it's possible to combine the two procedures into a single operation, without undue complications. April 23, 2008 NEW YORK (Reuters Health) - Increasing attention to palliative care has reduced suffering for children with cancer in recent years, according to a new report. Cholesterol drugs destroy esophageal cancer cells April 21, 2008 NEW YORK (Reuters Health) - Drugs that are commonly used to lower cholesterol can block the proliferation and promote the destruction of esophageal cancer cells in the laboratory, according to a report in the American Journal of Gastroenterology by UK researchers April 21, 2008 NEW YORK (Reuters Health) - For the first time, researchers have evidence of an association between renal cell carcinoma and multiple myeloma, a type of blood cancer, one that "cannot be explained by random incidence alone," they say. April 16, 2008 SAN DIEGO (Reuters) - New research shows a sharp drop in U.S. breast cancer cases in recent years was limited to white women, possibly because they abandoned hormone replacement therapy in greater numbers than minority groups. April 16, 2008 NEW YORK (Reuters Health) - The results of a mid-development stage clinical trial suggest that an experimental pan-VEGF inhibitor called cediranib may help shrink tumors and prolong survival in patients with recurrent glioblastoma. April 11, 2008 NEW YORK (Reuters Health) - Elderly patients with metastatic colon cancer, those between 76 and 80 years of age, have response and survival rates similar to their younger counterparts when given a treatment approach that includes stop-and-go oxaliplatin. April 11, 2008 NEW YORK (Reuters Health) - The results of a study published in the April issue of the International Journal of Cancer suggest that tobacco smoking and moderate-to-high alcohol consumption negatively affect the survival of patients with non-Hodgkin lymphoma (NHL). April 9, 2008 NEW YORK (Reuters Health) - New research indicates that breast MRIs performed in BRCA mutation carriers yield a high rate of false-positive results, yet this appears to have little impact on a woman's choice to undergo or not undergo prophylactic mastectomy. April 9, 2008 NEW YORK (Reuters Health) - Inhibition of the mammalian target of rapamycin (mTOR) pathway by everolimus works in concert with epithelial growth factor receptor (EGFR) inhibitors in human tumors both sensitive and resistant to anti-EGFR drugs, according to Italian researchers. April 9, 2008 TORONTO (Reuters Life!) - Humor can bring a human touch and help to relieve tension and worries associated with hospital care, Canadian researchers said on Wednesday. April 8, 2008 CHICAGO (Reuters) - An experimental treatment in mice showed promise in reversing a rare blood disease that can cause leukemia, U.S. researchers said on Monday, offering a glimpse of how the drug may work as it begins testing in humans. April 8, 2008 NEW YORK (Reuters Health) - Among survivors of childhood acute lymphoblastic leukemia (ALL) treated in the 1970s and 1980s, approximately one in five have developed another severe chronic medical condition or have died 25 years after their cancer diagnosis, the results of a long-term study suggest. However, long-term outcomes in the future may be better. April 7, 2008 NEW YORK (Reuters Health) - Patients who are being treated for advanced colorectal, ovarian or testicular cancer are living longer than they have in the past, a research team from the National Cancer Institute, Bethesda, Maryland, reports in the May 15th issue of the journal Cancer, published online today. April 7, 2008 NEW YORK (Reuters Health) - The use of hormone treatment for prostate cancer has declined, offset only in part by increases in surgical testicle removal, since Medicare reduced reimbursement for administration of these drugs that block testosterone starting in 2004. April 2, 2008 LONDON (Reuters) - Scientists have found important genetic differences between people that may help explain why some smokers get lung cancer and others do not. April 2, 2008 NEW YORK (Reuters) - Pfizer Inc said on Tuesday it was halting a late stage study of its experimental drug for advanced melanoma after data showed it was no better than standard chemotherapy. Copyright 2008 Reuters. Click for Restrictions.
|
